Braveheart Investment Group plc
07 April 2008
For release 07.00, 7 April 2008
Braveheart Investment Group plc
('Braveheart' or the 'Group')
INVESTMENT IN CONJUNCT LTD
('the Company')
Braveheart (AIM: BRH), the technology commercialisation and investment
management company, announces that it has invested £300,000 in Conjunct Limited.
Braveheart led the funding round alongside investors LINC Scotland and Scottish
Enterprise's Co-Investment Fund.
Founded in 2003, as a start-up from Heriot-Watt University, Conjunct was
established to commercialise disruptive technology for short range, high-speed
optical communications. The Company has developed technology specifically for
the datacoms market, the size of which has typically been restricted due to the
high cost and specification of components. Conjunct's Fibre-Lyte technology aims
to significantly increase performance over existing copper-based systems.
This funding will enable Conjunct to focus on fully developing its Fibre-Lyte
technology which will be licensed to a range of industrial partners. It will
also be used to embed the Fibre-Lyte technology in a range of value added
products. Discussions are already underway with a number of potential customers.
Commenting on the investment, Geoffrey Thomson, Chief Executive of Braveheart
said, 'We are delighted to be investing in a Company with such an impressive
proprietary technology. Conjunct has designed products, which will provide
significant benefits to connections for optical communications across the
datacoms market. Over the past five years the Company has built an impressive
Board of advisers and secured initial early stage funding. We are pleased to be
supporting them through this, the next stage in their growth and development.'
Ken Allstaff, Chief Executive of Conjunct, said; 'We have reached a new phase in
our product development and are very gratified that Braveheart are now on board
as an investor and adviser. They have an outstanding track record in supporting
early stage technology companies and we are confident that with their backing we
can accomplish our potential as we commercialise our pioneering technology.'
For further information please visit www.braveheart-ventures.co.uk or contact:
Braveheart Investment Group Tavistock Communications (for Braveheart)
Geoffrey Thomson, Chief Executive Clemmie Carr / Simon Hudson
Tel: 01738 587555 Tel: 020 7920 3150
gthomson@braveheart-ventures.co.uk ccarr@tavistock.co.uk
Conjunct Ltd.
Ken Allstaff
Chief Executive Officer
Tel: 01887 820412
ken.allstaff@conjunct.co.uk
Note to Editors
Braveheart was formed in 1997 by four Scottish businessmen as a co-investment
vehicle in order to pool their money and knowledge, increase diversification and
also reduce risk.
It makes investments in young, emerging, unlisted companies where there is
potential for significant growth, through the successful commercialisation of
their IP. Typically, Braveheart's investments are focused on British companies
with potential global technology solutions. However, the Group also maintains
limited exposure to more traditional businesses.
Braveheart's portfolio ranges from start-up companies to businesses, which are
close to an IPO or sale. Each year out of several hundred business plans
received, around ten investments are made, all of which demonstrate attractive
exit potential. These opportunities emanate from Braveheart's network of
contacts, which includes the Group's own clients, and close relationships with
science parks and universities. Braveheart has formal relationships with seven
universities and two business parks, giving it unique access to IP and start-up
companies emanating from them.
This information is provided by RNS
The company news service from the London Stock Exchange